John M Burke, MD

Research Reports

Treatment Pathways for First-Line Metastatic Non-Small Cell Lung Cancer: Cost and Survival

10/21/2020

Aimee Ginsburg , PharmD, BCPS;

J. Russell Hoverman , MD, PhD;

Angela Hsieh , PharmD, BCOP;

Kartik Konduri , MD;

Leslie T. Busby , MD;

Lalan Wilfong , MD;

John M. Burke , MD;

Marcus A. Neubauer , MD;

Abstract: Value Pathways powered by NCCN™ provides oncologists with a list of clinically proven treatment options that support the delivery of high-quality, cost-effective cancer care. We evaluated the economic and...

...

10/21/2020

Journal of Clinical Pathways

Research Reports

Barriers to Lymphoma Clinical Practice Guideline Adherence: A Pilot Mixed-Methods Research Study

04/16/2019

John M. Burke , MD;

Mihaela C. Munteanu , EdD, MS;

Abstract: Little is published about adherence barriers to lymphoma clinical practice guidelines (CPGs). This article examines the most frequent barriers to adherence to lymphoma CPGs. An explanatory sequential...

...

04/16/2019

Journal of Clinical Pathways